The 20 Best Hypothalamic Hamartomas Doctors in California, US

Steven Chang is a Neurosurgery specialist and a General Surgeon in Palo Alto, California. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Arteriovenous Malformation, Meningioma, Cerebral Arteriovenous Malformation, Awake Craniotomy, and Gamma Knife Radiosurgery.

Benjamin Chung is a Urologist and a General Surgeon in Stanford, California. Dr. Chung is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Chromophobe Renal Cell Carcinoma, Nephrectomy, and Cystectomy.

Dr. Tsai was born in New York City and raised in rural Wisconsin. Since leaving the north woods, he has crisscrossed the country for his education and training, consistently earning recognition along the way for exceptional achievement. He graduated Summa Cum Laude from Harvard University as a member of Phi Beta Kappa. As a student at the prestigious School of Medicine at Washington University in Saint Louis, Dr. Tsai's education was fully supported by a merit-based George Wilson Distinguished Student Scholarship. He earned his M.D. and graduated Alpha Omega Alpha with a Merck Manual Award – an award given to three graduates for outstanding academic achievement. He completed his internship at the University of California, San Francisco, before being awarded the Bank of America Giannini Foundation Medical Research Fellowship and the Knights Templar Eye Foundation Pediatric Ophthalmology Research Grant to spend two years in the Ocular Oncology Laboratory at UCSF developing improved methods of genetic testing for patients with retinoblastoma. He then headed east for his residency in ophthalmology at the Wilmer Eye Institute at Johns Hopkins, where he first met his future colleagues, Drs. Joel Pearlman, Rob Equi, and Margaret Chang. He then returned to UCSF to complete his clinical fellowship in ocular oncology in 2006-7.Dr. Tsai has served on the academic faculty at the Wilmer Eye Institute and at UCSF. He has published papers and presented work at national meetings on retinoblastoma, uveal melanoma, and intraocular lymphoma. He has also served as a peer-reviewer for several journals, including Ophthalmology and Archives of Ophthalmology. He is a member of the American Academy of Ophthalmology, the American Medical Association, and the American Society of Retina Specialists. He is a past President, Program Chair, and Secretary of the Alta Ophthalmology Society in Sacramento. He is board certified by the American Board of Ophthalmology.Aside from his mission to provide compassionate care for his patients, Dr. Tsai enjoys eating and he tries to compensate for this by indoor rock climbing and chasing after his two young children. On Sundays in the fall, he shows his Wisconsin roots as a die-hard Green Bay Packers fan.We provide exceptional care and compassionate service to optimize the vision of patients with retinal disease. Dr. Tsai is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Melanoma of the Eye, Choroid Plexus Carcinoma, Retinal Detachment, and Metastatic Uveal Melanoma.

Dr. Umesh Masharani is an endocrinologist who cares for patients with diabetes and thyroid disorders. He also has an endocrine faculty practice. Masharani's research focuses mainly on diabetes, with a particular interest in insulin resistance. He collaborates with colleagues in the family medicine departments to examine the relationships among glucose control, depression and psychosocial stress in people with diabetes. He is part of the islet auto-transplantation group, which has an active program managing patients who require surgical removal of the pancreas for chronic pancreatitis and are candidates for islet auto-transplant, a procedure that allows the patient's body to continue producing insulin. The islet transplant group is also studying donor islet transplants as a treatment for type 1 diabetes. In addition, Masharani is collaborating with Dr. George Brooks, a professor of integrative biology at the University of California, Berkeley, to examine the impact of exercise and aging on mitochondrial function. Masharani earned his bachelor's degree in physiological sciences at the University of Oxford. He earned his medical degree at Middlesex Health in London. He completed his residency in internal medicine at University Hospitals Birmingham NHS Foundation Trust in Birmingham, England. He completed a fellowship in endocrinology at UCSF. Dr. Masharani is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Anaplastic Thyroid Cancer, Thyroid Cancer, and Islet Cell Transplantation.

Dr. Robert Bhisitkul is an ophthalmologist and retina specialist who provides medical and laser treatment for macular degeneration, diabetic retinopathy and other retinal diseases. He also performs surgery on macular hole and macular pucker (conditions that cause blurred or distorted vision), retinal detachment and complications of diabetic eye disease. Bhisitkul recruits patients to participate in UCSF clinical trials on novel therapies for macular degeneration and diabetic retinopathy, and also for studies on long-term outcomes for treatments such as surgically implantable devices that deliver medication. He also conducts research on retinal disease mechanisms and surgical innovations. With the USCF Department of Bioengineering and Therapeutic Sciences, he is collaborating on a project to develop a bioengineered polymer device for ocular drug delivery. Bhisitkul earned his medical degree at Stanford University School of Medicine and his doctoral degree in neurosciences at Yale University. He completed a residency in ophthalmology and a vitreoretinal fellowship at Harvard Medical School and Massachusetts Eye and Ear. Bhisitkul has received the Achievement Award of the American Academy of Ophthalmology. He has published more than 60 papers in clinical and scientific journals. He serves on the editorial board of American Journal of Ophthalmology Case Reports and has served as associate editor of the British Journal of Ophthalmology. Bhisitkul is an associate examiner for the American Board of Ophthalmology and has served on the exam committee of Kuwait's ophthalmology board. Dr. Bhisitkul is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Vein Occlusion, Retinal Artery Occlusion, and Vitrectomy.

Madhu Rao is an Endocrinologist in San Francisco, California. Dr. Rao is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. Her top areas of expertise are Follicular Thyroid Cancer, Anaplastic Thyroid Cancer, Thyroid Cancer, and Papillary Thyroid Cancer.

I provide consultation services to primary care physicians. I try to provide highest quality care under the restraints of insurance and available resources. I will try to accomodate any insurance or healthcare agency within the limits of our care system. I prefer to provide clinical competence and do not rely on expensive technical procedures. Dr. Goldie is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Lennox-Gastaut Syndrome (LGS), Seizures, Infant Epilepsy with Migrant Focal Crisis, and Epilepsy in Children.

Behrouz Salehian is an Endocrinologist in Duarte, California. Dr. Salehian has been practicing medicine for over 47 years and is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Thyroid Cancer, Anaplastic Thyroid Cancer, Papillary Thyroid Cancer, and Follicular Thyroid Cancer.

Andrew Hoffman is an Endocrinologist in Stanford, California. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Growth Hormone Deficiency (GHD), Hypopituitarism, Pediatric Growth Hormone Deficiency, Hormone Replacement Therapy (HRT), and Colonoscopy.

Caroline Wallner is a Urologist in Burbank, California. Dr. Wallner has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Kidney Stones, and UPJ Obstruction.

Darius Moshfeghi is an Ophthalmologist in Palo Alto, California. Dr. Moshfeghi is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Retinopathy of Prematurity, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Vitrectomy, and Trabeculectomy.

Lawrence Recht is a Neurologist in Stanford, California. Dr. Recht is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Rebecca Seekamp is a primary care provider, practicing in Family Medicine in Palo Alto, California. Dr. Seekamp is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. Her top areas of expertise are Feingold Syndrome, Nephrotic Syndrome, Congenital Nephrotic Syndrome, and Phacomatosis Pigmentokeratotica.

Lawrence Shuer is a Neurosurgery provider in Stanford, California. Dr. Shuer is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Meningioma, Choroid Plexus Papilloma, Pallister-Hall Syndrome, Awake Craniotomy, and Thrombectomy.

Harcharan Gill is a Urologist in Stanford, California. Dr. Gill is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Enlarged Prostate (BPH), Bladder Cancer, Prostate Cancer, Reconstructive Urology Surgery, and Nephrectomy.

Prithvi Mruthyunjaya is an Oncologist in Palo Alto, California. Dr. Mruthyunjaya is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Melanoma of the Eye, Uveal Melanoma, Retinal Detachment, Vitrectomy, and Trabeculectomy.

Zev Wainberg is an Oncologist in Santa Monica, California. Dr. Wainberg is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Gastroesophageal Junction Cancer, Pancreatic Cancer, Stomach Cancer, Pancreaticoduodenectomy, and Pancreatectomy.

Randall Hawkins is a Neurologist in San Diego, California. Dr. Hawkins is rated as an Advanced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Phacomatosis Pigmentokeratotica, Cowden Syndrome, Von Hippel-Lindau (VHL) Syndrome, and Phacomatosis Pigmentovascularis.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Bertil Damato is an Ophthalmologist in San Francisco, California. Dr. Damato is rated as an Experienced provider by MediFind in the treatment of Hypothalamic Hamartomas. His top areas of expertise are Uveal Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, Vitrectomy, and Iridectomy.